Covered recipient · General Payments record
GITANJALI M LOBO
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2024
$2,828.18
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,363.24 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $525.79 | 7 |
| ABBVIE INC. | $502.93 | 20 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $174.35 | 2 |
| UCB, Inc. | $84.47 | 1 |
| Janssen Biotech, Inc. | $29.86 | 1 |
| Aurinia Pharma U.S., Inc. | $15.97 | 1 |
| Pacira Pharmaceuticals Incorporated | $15.41 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.04 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894033 | CMS |
| ABBVIE INC. | $30.53 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894035 | CMS |
| ABBVIE INC. | $19.28 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894037 | CMS |
| ABBVIE INC. | $23.09 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894039 | CMS |
| ABBVIE INC. | $9.61 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894041 | CMS |
| ABBVIE INC. | $125.76 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894043 | CMS |
| ABBVIE INC. | $14.08 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894045 | CMS |
| ABBVIE INC. | $14.94 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894047 | CMS |
| ABBVIE INC. | $4.44 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894049 | CMS |
| ABBVIE INC. | $27.93 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894051 | CMS |
| ABBVIE INC. | $25.51 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894053 | CMS |
| ABBVIE INC. | $19.36 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894055 | CMS |
| ABBVIE INC. | $21.94 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894057 | CMS |
| ABBVIE INC. | $22.68 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894059 | CMS |
| ABBVIE INC. | $23.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894061 | CMS |
| ABBVIE INC. | $13.57 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894063 | CMS |
| ABBVIE INC. | $18.51 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894065 | CMS |
| ABBVIE INC. | $27.33 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894067 | CMS |
| ABBVIE INC. | $21.23 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894069 | CMS |
| ABBVIE INC. | $15.34 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104894071 | CMS |
| Amgen Inc. | $116.96 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111636664 | CMS |
| Amgen Inc. | $67.73 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117312541 | CMS |
| Amgen Inc. | $30.84 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111636672 | CMS |
| Amgen Inc. | $137.60 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111636666 | CMS |
| Amgen Inc. | $6.74 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111636674 | CMS |
| Amgen Inc. | $138.42 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111636668 | CMS |
| Amgen Inc. | $27.50 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111636670 | CMS |
| Aurinia Pharma U.S., Inc. | $15.97 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150686397 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.46 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101842416 | CMS |
| Janssen Biotech, Inc. | $29.86 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078668176 | CMS |
| Novartis Pharmaceuticals Corporation | $158.97 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087149844 | CMS |
| Novartis Pharmaceuticals Corporation | $15.38 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087149854 | CMS |
| Pacira Pharmaceuticals Incorporated | $15.41 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151245846 | CMS |
| UCB, Inc. | $84.47 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143517880 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.